PR Newswire Clinical TrialsOriginal article
Arcato Announces Phase 1 Clinical Trial Results and Closing of Fully Subscribed Financing Round
Phase 1positiveARC-001 GelPositive
AI Analysis
Summary
Arcato announced positive Phase 1 clinical trial results for ARC-001 Gel, demonstrating safety and durable analgesia following third molar surgery, while closing a fully subscribed financing round.
Clinical Trial Data
Phase
Phase 1
Primary Endpoint
Met
Outcome Details
ARC-001 Gel demonstrated safety following third molar surgery with exploratory analyses suggesting durable analgesia, reducing post-operative pain within first 24 hours and potentially up to 1 week as a single dose
Importance:5/10
Sentiment:
0.70
Phase 1 resultssafety dataanalgesiafinancing rounddental surgery
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 19, 2026 2:50 PM